Although concurrent EGFR-mutation and ALK-rearrangement in lung ADC is more frequent than initially anticipated [7–10, 36], we detected no ALK fusion-protein expression, i.e. no sign of ALK-rearrangement, in any of the 23 EGFR-mutated patients. Here, EGFR is linked to medical procedure.